Trial Profile
An Open-Label, Multicenter Study To Evaluate The Pharmacokinetics Of Single And Multiple Intravenous Doses Of Pantoprazole In Two Age Cohorts Of Hospitalized Pediatric Subjects 1 To 16 Years Of Age Who Are Candidates For Acid Suppression Therapy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2024
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacokinetics
- Sponsors Pfizer
- 10 Apr 2023 Status changed from recruiting to discontinued due to the infeasibility of enrolling the required number of participants per protocol in the 1 <2 years of age cohort.
- 10 Mar 2023 This trial has been discontinued in Slovakia, according to European Clinical Trials Database record.
- 16 Oct 2021 This trial has been completed in Germany, according to European Clinical Trials Database record.